1.Incentive structure in team-based learning: graded versus ungraded Group Application exercises.
Adam S DEARDORFF ; Jeremy A MOORE ; Colleen MCCORMICK ; Paul G KOLES ; Nicole J BORGES
Journal of Educational Evaluation for Health Professions 2014;11(1):6-
PURPOSE: Previous studies on team-based learning (TBL) in medical education demonstrated improved learner engagement, learner satisfaction, and academic performance; however, a paucity of information exists on modifications of the incentive structure of "traditional" TBL practices. The current study investigates the impact of modification to conventional Group Application exercises by examining student preference and student perceptions of TBL outcomes when Group Application exercises are excluded from TBL grades. METHODS: During the 2009-2010 and 2010-2011 academic years, 175 students (95.6% response rate) completed a 22-item multiple choice survey followed by 3 open response questions at the end of their second year of medical school. These students had participated in a TBL supplemented preclinical curriculum with graded Group Application exercises during year one and ungraded Group Application exercises during year two of medical school. RESULTS: Chi-square analyses showed significant differences between grading categories for general assessment of TBL, participation and communication, intra-team discussion, inter-team discussion, student perceptions of their own effort and development of teamwork skills. Furthermore, 83.8% of students polled prefer ungraded Group Application exercises with only 7.2% preferring graded and 9.0% indicating no preference. CONCLUSION: The use of ungraded Group Application exercises appears to be a successful modification of TBL, making it more "student-friendly" while maintaining the goals of active learning and development of teamwork skills.
Curriculum
;
Education, Medical
;
Exercise*
;
Humans
;
Learning*
;
Motivation*
;
Problem-Based Learning
;
Schools, Medical
;
Students, Medical
2.Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis.
Sheng-Lian YANG ; Erica HARNISH ; Thomas LEEUW ; Uwe DIETZ ; Erika BATCHELDER ; Paul S WRIGHT ; Jane PEPPARD ; Paul AUGUST ; Cecile VOLLE-CHALLIER ; Francoise BONO ; Jean-Marc HERBERT ; Juan Carlos IZPISUA BELMONTE
Protein & Cell 2012;3(12):934-942
Articular cartilage, which is mainly composed of collagen II, enables smooth skeletal movement. Degeneration of collagen II can be caused by various events, such as injury, but degeneration especially increases over the course of normal aging. Unfortunately, the body does not fully repair itself from this type of degeneration, resulting in impaired movement. Microfracture, an articular cartilage repair surgical technique, has been commonly used in the clinic to induce the repair of tissue at damage sites. Mesenchymal stem cells (MSC) have also been used as cell therapy to repair degenerated cartilage. However, the therapeutic outcomes of all these techniques vary in different patients depending on their age, health, lesion size and the extent of damage to the cartilage. The repairing tissues either form fibrocartilage or go into a hypertrophic stage, both of which do not reproduce the equivalent functionality of endogenous hyaline cartilage. One of the reasons for this is inefficient chondrogenesis by endogenous and exogenous MSC. Drugs that promote chondrogenesis could be used to induce self-repair of damaged cartilage as a non-invasive approach alone, or combined with other techniques to greatly assist the therapeutic outcomes. The recent development of human induced pluripotent stem cell (iPSCs), which are able to self-renew and differentiate into multiple cell types, provides a potentially valuable cell resource for drug screening in a "more relevant" cell type. Here we report a screening platform using human iPSCs in a multi-well plate format to identify compounds that could promote chondrogenesis.
Cell Differentiation
;
drug effects
;
Chondrocytes
;
cytology
;
drug effects
;
metabolism
;
Chondrogenesis
;
drug effects
;
Drug Evaluation, Preclinical
;
methods
;
Genes, Reporter
;
genetics
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
drug effects
;
metabolism
;
Keratinocytes
;
cytology
;
drug effects
;
metabolism
;
Luciferases
;
genetics
;
Peptides
;
chemical synthesis
;
metabolism
;
Reproducibility of Results
;
Small Molecule Libraries
;
pharmacology